ISEC Healthcare Inkomsten in het verleden
Verleden criteriumcontroles 4/6
ISEC Healthcare has been growing earnings at an average annual rate of 21.1%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 16% per year. ISEC Healthcare's return on equity is 15.4%, and it has net margins of 19.3%.
Belangrijke informatie
21.1%
Groei van de winst
17.0%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 9.7% |
| Inkomstengroei | 16.0% |
| Rendement op eigen vermogen | 15.4% |
| Nettomarge | 19.3% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe ISEC Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 72 | 14 | 13 | 0 |
| 30 Jun 24 | 71 | 13 | 13 | 0 |
| 31 Mar 24 | 70 | 13 | 12 | 0 |
| 31 Dec 23 | 70 | 13 | 12 | 0 |
| 30 Sep 23 | 70 | 13 | 12 | 0 |
| 30 Jun 23 | 69 | 13 | 12 | 0 |
| 31 Mar 23 | 68 | 14 | 11 | 0 |
| 31 Dec 22 | 63 | 13 | 10 | 0 |
| 30 Sep 22 | 59 | 12 | 10 | 0 |
| 30 Jun 22 | 49 | 9 | 9 | 0 |
| 31 Mar 22 | 43 | 8 | 9 | 0 |
| 31 Dec 21 | 40 | 7 | 9 | 0 |
| 30 Sep 21 | 37 | 6 | 8 | 0 |
| 30 Jun 21 | 40 | 7 | 8 | 0 |
| 31 Mar 21 | 36 | 5 | 8 | 0 |
| 31 Dec 20 | 36 | 5 | 8 | 0 |
| 30 Sep 20 | 38 | 6 | 9 | 0 |
| 30 Jun 20 | 37 | 5 | 9 | 0 |
| 31 Mar 20 | 42 | 7 | 9 | 0 |
| 31 Dec 19 | 43 | 7 | 9 | 0 |
| 30 Sep 19 | 42 | 7 | 8 | 0 |
| 30 Jun 19 | 41 | 7 | 8 | 0 |
| 31 Mar 19 | 41 | 9 | 8 | 0 |
| 31 Dec 18 | 40 | 8 | 8 | 0 |
| 30 Sep 18 | 39 | 8 | 8 | 0 |
| 30 Jun 18 | 39 | 9 | 8 | 0 |
| 31 Mar 18 | 38 | 8 | 8 | 0 |
| 31 Dec 17 | 37 | 8 | 7 | 0 |
| 30 Sep 17 | 36 | 7 | 7 | 0 |
| 30 Jun 17 | 33 | 7 | 7 | 0 |
| 31 Mar 17 | 32 | 7 | 7 | 0 |
| 31 Dec 16 | 31 | 6 | 7 | 0 |
| 30 Sep 16 | 29 | 5 | 7 | 0 |
| 30 Jun 16 | 28 | 4 | 7 | 0 |
| 31 Mar 16 | 27 | 4 | 7 | 0 |
| 31 Dec 15 | 27 | 3 | 7 | 0 |
| 30 Sep 15 | 27 | 2 | 8 | 0 |
| 30 Jun 15 | 26 | 2 | 8 | 0 |
| 31 Mar 15 | 24 | 2 | 7 | 0 |
| 31 Dec 14 | 22 | 2 | 6 | 0 |
| 30 Sep 14 | 19 | 3 | 4 | 0 |
| 31 Mar 14 | 18 | 3 | 3 | 0 |
| 31 Dec 13 | 18 | 3 | 3 | 0 |
Kwaliteitswinsten: 40T has high quality earnings.
Groeiende winstmarge: 40T's current net profit margins (19.3%) are higher than last year (19.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 40T's earnings have grown significantly by 21.1% per year over the past 5 years.
Versnelling van de groei: 40T's earnings growth over the past year (4%) is below its 5-year average (21.1% per year).
Winst versus industrie: 40T earnings growth over the past year (4%) exceeded the Healthcare industry -35.5%.
Rendement op eigen vermogen
Hoge ROE: 40T's Return on Equity (15.4%) is considered low.